betaFeedback

WorksComputer Science

From Adult Renal Masses to Pediatric Wilms Tumors: Evaluating Cross-Domain Generalization of Kidney Lesion Segmentation on MRI

Abstract

Deep learning segmentation models for pediatric oncology are often trained on small, single-center cohorts, whereas much larger datasets exist for adult diseases, such as kidney cancer. Whether models trained on adult renal lesions generalize to pediatric Wilms tumors remains unclear. We trained a segmentation model on single-sequence T1- or T2-weighted adult kidney MRI and evaluated it on a held-out adult test set and a pediatric Wilms tumor cohort, where it was compared with a pediatric-specific nnU-Net. Segmentation performance was quantified using the Dice similarity coefficient (DSC) and 95th-percentile Hausdorff distance. On the adult test set, the model achieved a median DSC of 0.86 for renal lesions. On the pediatric cohort, the adult-trained model achieved a median DSC of 0.85 compared with 0.90 for the pediatric-specific model. Despite differences in age, anatomy, and tumor type, the adult-trained model showed promising performance on pediatric Wilms tumors, with only a modest difference in median DSC compared with the pediatric-specific model. However, non-inferiority could not be shown, highlighting the value of pediatric training data. In future work, a fine-tuning strategy could be explored.

Introduction

Deep learning-based segmentation is increasingly used to support tumor volume assessment, treatment planning, and response monitoring in pediatric oncology. However, pediatric imaging datasets are inherently small because of the low incidence of pediatric cancers and the practical limitations in assembling multi-center datasets with expert annotations. Although Wilms tumor is the most common pediatric renal malignancy [1], research remains constrained by the scarcity of large, annotated imaging datasets [2], in contrast to the substantially larger cohorts available for adult renal diseases.

Whether models trained on much larger adult datasets can generalize effectively to the pediatric setting remains an open question. For CT-based abdominal organ segmentation, Chatterjee et al. showed that an adult-trained model (TotalSegmentator [3]) achieves significantly lower Dice similarity coefficients (DSCs) on pediatric than on adult CT (0.73 vs. 0.81), with the largest performance drops in smaller anatomical structures [4]. These findings motivate investigating whether a similar generalization gap exists for adult-to-pediatric lesion segmentation on MRI. To the best of our knowledge, this has not been previously investigated. Moreover, the lack of a publicly available adult MRI model for kidney cancer segmentation has so far limited direct assessment of adult-to-pediatric transfer.

In this work, we train a segmentation model on adult kidney lesion MRI and evaluate it on the pediatric Wilms tumor cohort previously used by Buser et al. [2]. Specifically, we (1) quantify the generalization gap between the adult model’s performance on an adult hold-out test set and its performance on pediatric data, and (2) directly compare the adult model with a pediatric-specific nnU-Net, on a per-case basis. To enable further evaluation of adult-to-pediatric transfer alongside existing public pediatric models [5], we release our adult model at https://github.com/DIAGNijmegen/oncology-kidney-abnormality-segmentation.

Materials and Methods

Data

Adult cohort. The adult MRI data consisted of 1794 MRI sequences from 689 patients (age 38–74 years, 450 male) acquired at Charité – Universitätsmedizin Berlin. It included cases of renal cell carcinoma, urothelial carcinoma, and oncocytoma, with T1-weighted, post-contrast fat-suppressed T1-weighted, and T2-weighted acquisitions. In previous work [6], a medical student annotated tumors, cysts and corresponding kidneys; kidneys without tumors remained unsegmented. In this work, we unified tumors and cysts to a more general class "renal mass" to reflect a single abnormality. Twenty percent of the data (138 patients, 359 sequences) were held out for in-domain (adult-on-adult) evaluation, with the remaining 80% used for training. The institutional ethics board approved retrospective use of the dataset for research. Dataset characteristics are summarized in Table 1.

Adult cohortPediatric cohort
InstitutionCharité – Universitätsmedizin BerlinPrincess Máxima Center for Pediatric Oncology
Use in this studyTraining and in-domain testExternal test (zero-shot)
Patients (sequences)689 (1794)45 (45)
Training551 (1435)–
Test138 (359)45 (45)
Age range38–74 years7–109 months
Sex (male)450 (65 %)22 (49 %)
DiagnosisRenal cell carcinoma, urothelial carcinoma, oncocytoma, renal cystsWilms tumor
SequencesT1w, fat-suppressed post-contrast T1w, T2wT2w
Annotated structuresTumor-bearing kidney, solid masses, cystsTumors
Solid masses
Components220852
Volume (ml)15.3 (3.9–65.8)200.2 (95.1–497.0)
Cysts
Components2432–
Volume (ml)0.6 (0.2–2.4)–

Table 1. Overview of the adult and pediatric cohorts. Renal mass volume is reported as the median and interquartile range.

Pediatric cohort. The pediatric test cohort consisted of MRI data acquired at Princess Máxima Center for Pediatric Oncology, comprising 45 patients with Wilms tumor (age 7–109 months, 22 male, 52 tumors, 7 bilateral) [2]. All scans were 3D T2-weighted acquisitions (1.5 T, voxel size = 0.83 mm, slice thickness = 1.15 mm), including manual reference segmentations of the lesions, annotated by technical physicians and checked by a radiologist. The institutional ethics board approved retrospective use of this dataset for research. Example images comparing adult to pediatric cases are shown in Figure 1b.

Figure 1. (a) Semi-supervised model training: MRSegmentator was used to localize both kidneys. A temporary nnU-Net was trained on manually annotated crops and used to generate pseudolabels for previously unlabeled kidneys. Manual and automatic annotations were then merged to train the final model. (b) Tumor examples from the adult and pediatric cohorts.

Model training

The reference annotations in the adult cohort only included kidneys and cysts ipsilateral to a solid tumor. This was insufficient for training a model, as the missing annotations for contralateral structures would affect the training loss. Consequently, we designed a semi-supervised training workflow to mitigate the issue of missing annotations, as depicted in Figure 1a.

First, we used the publicly available MRSegmentator model [7] to delineate contralateral kidneys. Notably, these delineations did not include potential renal masses and were therefore only used to calculate bounding boxes. For each MRI sequence, we computed two disjoint crops. The first enclosed the manual annotations while excluding the contralateral kidney. The second enclosed the contralateral kidney with a 3 cm margin. In cases where both kidneys were tumor-bearing, the reference annotations were used without cropping. Next, we trained a 3D nnU-Net-based segmentation network [8] exclusively on the manually annotated kidney crops and used the resulting model to predict masks for the contralateral structures.

Lastly, we merged the reference annotations and predicted contralateral segmentations into unified masks and trained a new, independent nnU-Net on the complete

sequences from the adult training partition. Notably, for the evaluation, we restricted our analysis to the crops around the manual annotations in the hold-out data. No fine-tuning or adaptation of any kind was performed on the pediatric data; all pediatric evaluations were strictly zero-shot.

Experimental design and evaluation

We addressed three research questions. First, we established an in-domain baseline by evaluating the adult model on the held-out adult test set. Second, we assessed cross-domain generalization by evaluating the same model on the pediatric Wilms tumor dataset. Third, we compared its performance in the pediatric setting with that of the pediatric-specific nnU-Net model developed by Buser et al. [2].

Segmentation performance was quantified using the Dice similarity coefficient (DSC) and 95th-percentile Hausdorff distance (HD95). Metrics were calculated for both kidney and renal mass classes in the adult dataset and for renal mass alone in the pediatric dataset. On the pediatric dataset, non-inferiority of the adult model relative to the pediatric-specific model was assessed using a paired Wilcoxon signed-rank test on DSC, with a pre-specified non-inferiority margin of δ=0.03\delta= 0.03 based on previously reported inter-reader variability in manual cyst annotations [9]. For adult-to-pediatric generalization, we did not perform significance testing because differences in tumor volumes, image sizes, and annotation protocols between datasets may independently affect segmentation metrics. Instead, we report these differences descriptively.

Results

Adult in-domain performance

We evaluated the adult MRI segmentation model on the adult hold-out test set, which consisted of 359 sequences from 138 patients. Across all sequence types, the model achieved a median kidney DSC of 0.92 (IQR: 0.87 – 0.94), and a median HD95 of 3.5 mm (IQR: 2.8 – 5.8). For renal mass segmentation, the median DSC was 0.86 (IQR: 0.79 – 0.91) and the median HD95 was 6.3 mm (IQR: 4.0 – 15.6). Performance varied by sequence type, with a median renal mass DSC of 0.87 for T1-weighted fat-suppressed sequences, 0.87 for T2-weighted sequences, and 0.84 for conventional T1-weighted sequences.

Generalization gap

The adult model was evaluated on a pediatric cohort of 45 patients with Wilms tumor. It achieved a median tumor DSC of 0.85 (IQR: 0.64 - 0.89) and a median HD95 of 11.0 mm (IQR: 6.8 - 16.8). This included 5 patients with a DSC of 0, of which in three cases the model did not produce any kidney or tumor segmentation (all in patients younger than 10 months).

Comparison with pediatric model

On the pediatric dataset, the pediatric-specific model achieved a median tumor DSC of 0.90 (IQR: 0.86 – 0.92), compared with 0.85 (IQR: 0.64 – 0.89) for the adult model. The corresponding median HD95 values were 6.6 mm (IQR: 4.9 – 11.8) and 11.0 mm (IQR: 6.8 – 16.8), respectively. Non-inferiority of the adult model to the pediatric-specific model could not be demonstrated. A per-case DSC comparison is presented in Figure 2. In Figure 3, we present an analysis comparing the performance across patients’ age groups for the adult (left) and pediatric (right) model.

Figure 2. Case-level DSC comparison between the adult- and pediatric-trained models on the Wilms tumor cohort.

Figure 3. Subgroup analysis comparing the performance (in DSC) per patient age group for the adult (left) and pediatric (right) models.

Discussion and conclusion

In the adult cohort, the model achieved a median kidney DSC of 0.92. Although this is lower than the DSC of up to 0.95 reported for both kidneys by MRSegmentator [7], direct comparison is limited because our evaluation was restricted to tumor-affected kidneys. For renal lesion segmentation, the model achieved a DSC of 0.86, which is comparable to previously reported performance on CT [10], and within the range of reported results for MRI [11, 12, 13].

Despite not being trained on Wilms tumors or pediatric data, the model generalized to the pediatric cohort, potentially benefiting from the broad "renal mass" class, which included multiple types of renal anomalies. However, performance was lower than that of the pediatric-specific model, with no tumor segmentation in four cases. This gap may reflect differences in both disease and anatomical scale. Wilms tumors differ morphologically from the renal lesions represented in the adult training data, and pediatric images contain substantially smaller anatomical structures. These scale differences may be particularly relevant given the model’s fixed isotropic resampling, which can reduce the effective resolution of small structures. We hypothesized that the performance of the adult-trained model would correlate with patient age, as MRI of older children should be more similar to the training data distribution. However, interestingly, the DSC performance of the adult model did not systematically increase with patient age.

This study has limitations. Most importantly, the comparison between the adult and pediatric models was not fully symmetric: the pediatric model was evaluated using cross-validation on the pediatric dataset, whereas the same dataset was used as an external test set for the adult model. This limits direct interpretation of the performance difference. Furthermore, the pediatric cohort was relatively small, and the datasets differed in acquisition characteristics and annotation protocols, making it difficult to attribute the observed performance difference to any single source of domain shift.

Future work should investigate whether domain adaptation or targeted fine-tuning can improve adult-to-pediatric transfer while reducing the need for large pediatric training cohorts. Such approaches could be valuable for rare pediatric diseases, where assembling large annotated datasets is challenging.

Overall, the adult model demonstrated the ability to generalize to pediatric Wilms tumor MRI. However, the observed performance gap relative to a pediatric-specific model indicates that large adult datasets cannot fully compensate for pediatric-specific differences in anatomy, imaging, and disease presentation. Dedicated pediatric models therefore remain valuable, while the demonstrated transferability of the adult model suggests a potential role for large adult datasets in supporting pediatric annotation and model development.

Acknowledgement. This research is funded by the European Union under HORIZON-HLTH-2022: COMFORT (101079894). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.

References

  1. [1]Spreafico F, Bellani FF. Wilms’ Tumor: Past, Present and (Possibly) Future. Expert Review of Anticancer Therapy. 2006;6(2):249–58.pubmed.ncbi.nlm.nih.gov/16445377
  2. [2]Buser MAD, Steeg AFW van der, Wijnen MHWA, Fitski M, Tinteren H van, Heuvel-Eibrink MM van den et al. Radiologic versus Segmentation Measurements to Quantify Wilms Tumor Volume on MRI in Pediatric Patients. Cancers. 2023;15(7):2115.DOI
  3. [3]Wasserthal J, Breit HC, Meyer MT, Pradella M, Hinck D, Sauter AW et al. TotalSegmentator: Robust Segmentation of 104 Anatomic Structures in CT Images. Radiology: Artificial Intelligence. 2023;5(5):e230024.DOI
  4. [4]Chatterjee D, Kanhere A, Doo FX, Zhao J, Chan A, Welsh A et al. Children Are Not Small Adults: Addressing Limited Generalizability of an Adult Deep Learning CT Organ Segmentation Model to the Pediatric Population. Journal of Imaging Informatics in Medicine. 2025;38:1628–41.DOI
  5. [5]Buser M, de Groot N, Simons D, Littooij A, Wijnen M, van de Ven C et al. Deep learning-based Wilms tumor segmentation to create 3D models for surgical planning: Implementation in the clinical workflow. Journal of Pediatric Surgery. 2026;61(7):163151.DOI
  6. [6]Häntze H, Xu L, Rattunde MN, Donle L, Dorfner FJ, Hering A et al. MRI annotation using an inversion-based preprocessing for CT model adaptation. European Radiology Experimental. 2025;9(1):93.DOI
  7. [7]Häntze H, Xu L, Mertens CJ et al. Segmenting whole-body MRI and CT for multiorgan anatomic structure delineation. Radiology: Artificial Intelligence. 2025;7(6):e240777.DOI
  8. [8]Isensee F, Jaeger PF, Kohl SAA, Petersen J, Maier-Hein KH. nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation. Nature Methods. 2021;18(2):203–11.DOI
  9. [9]Sore R, Cathier P, Vlachomitrou AS, Bailleux J, Arnaud K, Juillard L et al. Deep Learning-Based Segmentation of Kidneys and Renal Cysts on T2-weighted MRI from Patients with Autosomal Dominant Polycystic Kidney Disease. European Radiology Experimental. 2024;8(1):122.
  10. [10]de Boer S, Hांntze H, Venkadesh KV, Buser MAD, Mamani GEH, Xu L et al. Robust Renal Mass Segmentation on CT: A Validation Study of an AI-Based Framework. Machine Learning for Biomedical Imaging. 2026;(May 2026 issue):229–51.DOI
  11. [11]Anari PY, Lav N, Chaurasia A, Gopal N, Samimi S, Harmons et al. Automatic Segmentation of Clear Cell Renal Cell Tumors, Kidney, and Cysts in Patients with von Hippel-Lindau Syndrome Using U-net Architecture on Magnetic Resonance Images. ArXiv. 2023:arXiv:2301.02538v1.arxiv.org/abs/2301.02538
  12. [12]Anusha C, Rao KN, Zhao TL, A Systematic Review on Automatic Segmentation of Renal Tumors and Cysts Using Various Convolutional Neural Network Architectures in Radiological Images. Computers in Biology and Medicine. 2025;198:111177.DOI
  13. [13]Payarut S, Lee JS, Obi T, Kobayashi M, Tanaka H, Matsuoka Y et al. Enhancing Kidney Tumor Segmentation in MRI Using Multi-Modal Medical Images With Transformers. IEEE Access. 2025;13:191253–66.

Paper details

vlnc:W_dqvv9g6y
Version
v1 · latest
Published
Fresh — added to the Hub within the last 30 days
Added
License
CC BY 4.0
Usage

views · 0

downloads · 0

A view counts once per browser per day, a download each time the PDF is requested.

  • Computer Science

Not recorded for this paper

View statement
Looking for related papers…
Contents